Biotech · Private company · State University, AR, US
Biostrategies, Lc
Track this companyFree. Adds Biostrategies, Lc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Treatment of GM1 gangliosidosis CNS manifestations by AAV systemic expression of lectin-enhanced enzymeFiscal year 2026 · $1.5MNIH RePORTER 5R44NS141514-02 · fetched Nov 12, 2026
- Treatment of GM1 Gangliosidosis CNS Manifestations by AAV Systemic Expression of Lectin-Enhanced EnzymeFiscal year 2025 · $1.5MNIH RePORTER 1R44NS141514-01A1 · fetched Nov 12, 2026
- Gene Therapy that Systemically Produces Brain-penetrating Replacement Enzyme for MPS IIIA (Sanfilippo A Syndrome)Fiscal year 2024 · $1.5MNIH RePORTER 5R44NS134453-02 · fetched Nov 12, 2026